The intervention of exosomes from osteoblast ASC in cancer stem cells could significantly reduce the expression of ATP-binding box (ABC) transporters, breast cancer gene family (BCRA1 and BCRA2), ErbB gene family and other drug-resistant genes, helping to overcome the treatment resistance [38]. The gene discussed is EGFR; the disease is cancer.